Article · 19 Feb 2026
Case reportPublished 2019
Romiplostim as a Viable and Long-term Remedy for Refractory Immune Thrombocytopenia and Concomitant Small B-Cell Lymphoma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterized by immune-mediated destruction of otherwise normal platelets and can be either primary, without obvious initiating or underlying cause, or secondary ITP due to an underlying disease or drug exposure. The goals of therapy for ITP include achieving an adequate platelet level for hemostasis and minimizing toxicities with current options including: corticosteroids, rituximab, splenectomy, intravenous gamma globulin (IVIG), Anti-D, and thrombopoietin receptor agonists (TPO) like romiplostim and eltrombopag. TPO mimetics like romiplostim have emerged as viable and practical option in relapsed and refractory ITP. We present a 70-year-old Caucasian male patient with chronic lymphocytic leukemia/small cell lymphoma (CLL/SLL) related secondary ITP who had been maintained for nearly a decade on romiplostim after failing all other options of therapy. We report this case to demonstrate the efficacy and sustainability of romiplostim use in the relapse/ refractory ITP in such a patient who failed to respond to other therapeutic options.
Subjects
HaematologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Blood & Lymph.
Commentary · 1 Jan 2026
Commentary on Prosthetic Valve Dysfunction Post-Bevacizumab: A TAVR Thrombosis
Commentary · 1 Jan 2026
The Interaction of Blood and Lymphatic Systems: Insights for Modern Hemato-Lymphatic Research
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Blood & Lymph
- SubjectHaematology
- BylineArticles whose byline prints “Germame Ajebo”
- BylineArticles whose byline prints “Paul Dainer”
- BylineArticles whose byline prints “Jeremy Pantin”
- BylineArticles whose byline prints “Nathan Ryan”
- BylineArticles whose byline prints “Charles Bruker”
